Literature DB >> 12531619

Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.

G M Brittenham, D G Nathan, N F Olivieri, M J Pippard, D J Weatherall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531619     DOI: 10.1016/s0140-6736(03)12223-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions.

Authors:  Ellis J Neufeld
Journal:  Blood       Date:  2006-05-01       Impact factor: 22.113

Review 2.  Magnetic resonance imaging measurement of iron overload.

Authors:  John C Wood
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

3.  MRI detects myocardial iron in the human heart.

Authors:  Nilesh R Ghugre; Cathleen M Enriquez; Ignacio Gonzalez; Marvin D Nelson; Thomas D Coates; John C Wood
Journal:  Magn Reson Med       Date:  2006-09       Impact factor: 4.668

4.  New developments and controversies in iron metabolism and iron chelation therapy.

Authors:  Christina N Kontoghiorghe; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2016-03-26

5.  Pathophysiology and Clinical Manifestations of the β-Thalassemias.

Authors:  Arthur W Nienhuis; David G Nathan
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

Review 6.  Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases.

Authors:  Catherine M Cahill; Debomoy K Lahiri; Xudong Huang; Jack T Rogers
Journal:  Biochim Biophys Acta       Date:  2008-12-29

7.  B(C6F5)3-catalyzed dehydrogenative cyclization of N-tosylhydrazones and anilines via a Lewis adduct: a combined experimental and computational investigation.

Authors:  Murali Mohan Guru; Sriman De; Sayan Dutta; Debasis Koley; Biplab Maji
Journal:  Chem Sci       Date:  2019-07-05       Impact factor: 9.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.